EP0977590A4 - HUMAN MONOCLONAL ANTIBODIES - Google Patents

HUMAN MONOCLONAL ANTIBODIES

Info

Publication number
EP0977590A4
EP0977590A4 EP97913749A EP97913749A EP0977590A4 EP 0977590 A4 EP0977590 A4 EP 0977590A4 EP 97913749 A EP97913749 A EP 97913749A EP 97913749 A EP97913749 A EP 97913749A EP 0977590 A4 EP0977590 A4 EP 0977590A4
Authority
EP
European Patent Office
Prior art keywords
monoclonal antibodies
human monoclonal
human
antibodies
monoclonal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP97913749A
Other languages
German (de)
French (fr)
Other versions
EP0977590A1 (en
Inventor
Keith Charles Deen
Susan Beth Dillon
Terence Graham Porter
Raymond Whitney Sweet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Publication of EP0977590A1 publication Critical patent/EP0977590A1/en
Publication of EP0977590A4 publication Critical patent/EP0977590A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—RNA viruses
    • C07K16/11—Paramyxoviridae (F); Pneumoviridae (F), e.g. respiratory syncytial virus [RSV]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/55—Fab or Fab'

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
EP97913749A 1996-11-01 1997-10-23 HUMAN MONOCLONAL ANTIBODIES Withdrawn EP0977590A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US3014996P 1996-11-01 1996-11-01
US30149P 1996-11-01
PCT/US1997/019203 WO1998019704A1 (en) 1996-11-01 1997-10-23 Human monoclonal antibodies

Publications (2)

Publication Number Publication Date
EP0977590A1 EP0977590A1 (en) 2000-02-09
EP0977590A4 true EP0977590A4 (en) 2001-03-14

Family

ID=21852781

Family Applications (1)

Application Number Title Priority Date Filing Date
EP97913749A Withdrawn EP0977590A4 (en) 1996-11-01 1997-10-23 HUMAN MONOCLONAL ANTIBODIES

Country Status (4)

Country Link
EP (1) EP0977590A4 (en)
JP (1) JP2001510329A (en)
CA (1) CA2270288A1 (en)
WO (1) WO1998019704A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR030019A1 (en) * 1999-05-18 2003-08-13 Smithkline Beecham Corp HUMAN MONOCLONAL ANTIBODIES AND FUNCTIONAL FRAGMENTS OF THE SAME, A PROCEDURE FOR THEIR PRODUCTION, PHARMACEUTICAL COMPOSITIONS THAT INCLUDE THEM, A NUCLEIC ACID ISOLATED MOLECULA, A RECOMBINANT PLASMIDE, A HOSPED DIFFERENT USE OF A MUSCLE
US20020004046A1 (en) * 2000-05-03 2002-01-10 Johnson Leslie S. Combination therapy of respiratory diseases using antibodies
JP2005522996A (en) * 2001-11-02 2005-08-04 セントカー・インコーポレーテツド RSV proteins, antibodies, compositions, methods and uses
GB0210121D0 (en) 2002-05-02 2002-06-12 Celltech R&D Ltd Biological products
US7070786B2 (en) 2003-06-06 2006-07-04 Centocor, Inc. RSV proteins, antibodies, compositions, methods and uses
LT2285408T (en) 2008-06-05 2019-01-25 Ablynx N.V. Amino acid sequences directed against envelope proteins of a virus and polypeptides comprising the same for the treatment of viral diseases
JP5575377B2 (en) 2008-07-18 2014-08-20 シスメックス株式会社 RS virus detection kit and immunochromatography test device using anti-RS virus monoclonal antibody, and novel anti-RS virus monoclonal antibody
PT2438087T (en) 2009-06-05 2017-08-04 Ablynx Nv HUMAN RESPIRATORY SYNCHRONOUS (HRSV) TRIVALENT NANOBODY CONSTRUCTIONS FOR THE PREVENTION AND / OR TREATMENT OF RESPIRATORY TRACT INFECTIONS
WO2011064382A1 (en) 2009-11-30 2011-06-03 Ablynx N.V. Improved amino acid sequences directed against human respiratory syncytial virus (hrsv) and polypeptides comprising the same for the prevention and/or treatment of respiratory tract infections
JO3555B1 (en) 2015-10-29 2020-07-05 Merck Sharp & Dohme An antibody that inactivates the human pneumonia virus

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994006448A1 (en) * 1992-09-16 1994-03-31 The Scripps Research Institute Human neutralizing monoclonal antibodies to respiratory syncytial virus

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994006448A1 (en) * 1992-09-16 1994-03-31 The Scripps Research Institute Human neutralizing monoclonal antibodies to respiratory syncytial virus

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
See also references of WO9819704A1 *
WYDE P R ET AL: "Evaluation of the protective efficacy of reshaped human monoclonal antibody RSHZ19 against respiratory syncytial virus in cotton rats.", PEDIATRIC RESEARCH, (1995 OCT) 38 (4) 543-50., XP000972993 *

Also Published As

Publication number Publication date
WO1998019704A1 (en) 1998-05-14
CA2270288A1 (en) 1998-05-14
JP2001510329A (en) 2001-07-31
EP0977590A1 (en) 2000-02-09

Similar Documents

Publication Publication Date Title
NO955167D0 (en) Monoclonal anti-
NO985464D0 (en) Concentrated antibody preparation
IL136335A0 (en) Monoclonal human natural antibodies
DK1516629T3 (en) Humanized anti-CD-11a antibodies
DK0837927T3 (en) Anti-CD80 antibodies
DE69617896D1 (en) Human monoclonal antibody against VEGF
CY2008003I2 (en) HUMAN MONOCLONAL ANTIBODIES TO EPITERNAL GROWTH FACTOR RECEPTOR
FI965032A7 (en) Interleukin-5-specific recombinant antibodies
FI964845L (en) Anti-CD44v6 monoclonal antibodies
LV11630A (en) T-dog antigen receptor V region full length proteins
EP0832125A4 (en) HUMAN G PROTEIN RECEPTOR HGBER32
DE69528180D1 (en) MODIFIED Whey Protein
FI970979L (en) Modified human C3 proteins
EP1178829A4 (en) HUMAN MONOCLONAL ANTIBODY
DE69738312D1 (en) HEPATITIS B MONOCLONAL ANTIBODIES
BR9610239A (en) Xcd32-allergen-fusion proteins
NO980719D0 (en) impervious
EP0977590A4 (en) HUMAN MONOCLONAL ANTIBODIES
NO981454L (en) Anti-FAS antibodies
FI972430A7 (en) Monoclonal antibody fragments with immunosuppressive activity
EP1012262A4 (en) HUMAN FREZZELED-LIKE PROTEIN
EP0919617A4 (en) MONOCLONAL ANTI-MP52 HUMAN ANTIBODIES
KR960036200U (en) cup
DE69615850D1 (en) G PROTEIN COUPLED RECEPTOR HNFD578
KR970007899U (en) parasol

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19990521

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): BE CH DE ES FR GB IT LI NL

A4 Supplementary search report drawn up and despatched

Effective date: 20010129

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): BE CH DE ES FR GB IT LI NL

RIC1 Information provided on ipc code assigned before grant

Free format text: 7A 61K 39/395 A, 7C 07K 16/10 B, 7G 01N 33/53 B, 7C 12N 15/13 B

17Q First examination report despatched

Effective date: 20010417

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20011030